Nathaniel Calloway insider trades

Open-market stock purchases and sales by Nathaniel Calloway, Director at Anebulo Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 1, 2022.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • ANEB Anebulo Pharmaceuticals, Inc: other filings, last Apr 4, 2025
  • LFCR Lifecore Biomedical, Inc \de\: other filings, last Jul 8, 2024

Get free alerts when Nathaniel Calloway files a new trade →